Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment
approximately 5-7% of people in Russia have diabetes. In addition, the number is growing every year. Diabetes treatment schemes mostly focused on normalizing the blood glucose level. To achieve it patients use the glucose meters. However, there are some technique differences between meters that coul...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-03-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/51 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849394402892447744 |
|---|---|
| author | A. U. Kulikov V. V. Babiy |
| author_facet | A. U. Kulikov V. V. Babiy |
| author_sort | A. U. Kulikov |
| collection | DOAJ |
| description | approximately 5-7% of people in Russia have diabetes. In addition, the number is growing every year. Diabetes treatment schemes mostly focused on normalizing the blood glucose level. To achieve it patients use the glucose meters. However, there are some technique differences between meters that could influence on the cost and effectiveness of diabetes and its complications treatment. This pharmacoeconomic research compared the cost-effectiveness and the budget impact results of using Contour TS, Accu-Chek Active and OneTouch Select. Research outcomes demonstrate the pharmacoeconomic advantages of using Contour TS as blood glucose meter in diabetes treatment schemes. |
| format | Article |
| id | doaj-art-28bafe054ded4e3895f28e15159bb057 |
| institution | Kabale University |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2015-03-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-28bafe054ded4e3895f28e15159bb0572025-08-20T03:40:00ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-03-0164535845Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatmentA. U. Kulikov0V. V. Babiy1The First Moscow State Medical University named after I.M. SechenovThe First Moscow State Medical University named after I.M. Sechenovapproximately 5-7% of people in Russia have diabetes. In addition, the number is growing every year. Diabetes treatment schemes mostly focused on normalizing the blood glucose level. To achieve it patients use the glucose meters. However, there are some technique differences between meters that could influence on the cost and effectiveness of diabetes and its complications treatment. This pharmacoeconomic research compared the cost-effectiveness and the budget impact results of using Contour TS, Accu-Chek Active and OneTouch Select. Research outcomes demonstrate the pharmacoeconomic advantages of using Contour TS as blood glucose meter in diabetes treatment schemes.https://www.pharmacoeconomics.ru/jour/article/view/51diabetesglucose metercontour tsaccu-chek activeonetouch selectpharmacoeconomic studiescost-effectiveness analysisbudget impact analysislife years gaineddiscount rate |
| spellingShingle | A. U. Kulikov V. V. Babiy Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment Фармакоэкономика diabetes glucose meter contour ts accu-chek active onetouch select pharmacoeconomic studies cost-effectiveness analysis budget impact analysis life years gained discount rate |
| title | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment |
| title_full | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment |
| title_fullStr | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment |
| title_full_unstemmed | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment |
| title_short | Pharmacoeconomic analysis of blood glucose meter Contour TS in diabetes treatment |
| title_sort | pharmacoeconomic analysis of blood glucose meter contour ts in diabetes treatment |
| topic | diabetes glucose meter contour ts accu-chek active onetouch select pharmacoeconomic studies cost-effectiveness analysis budget impact analysis life years gained discount rate |
| url | https://www.pharmacoeconomics.ru/jour/article/view/51 |
| work_keys_str_mv | AT aukulikov pharmacoeconomicanalysisofbloodglucosemetercontourtsindiabetestreatment AT vvbabiy pharmacoeconomicanalysisofbloodglucosemetercontourtsindiabetestreatment |